デフォルト表紙
市場調査レポート
商品コード
1694761

医薬品サプライチェーンマネジメントの世界市場レポート 2025年

Pharmaceutical Supply Chain Management Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医薬品サプライチェーンマネジメントの世界市場レポート 2025年
出版日: 2025年03月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品サプライチェーンマネジメント市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3%で39億3,000万米ドルに成長します。予測期間の成長は、精密医療、回復力計画、データセキュリティ、eコマース統合、リアルタイムモニタリングと可視化、循環型経済への取り組みに起因すると考えられます。予測期間の主な動向には、デジタルトランスフォーメーション、技術の進歩、コラボレーションと可視化、環境の持続可能性、高度な分析とAIの統合、ブロックチェーン技術の採用などがあります。

医薬品需要の増加が医薬品サプライチェーンマネジメント市場の成長を牽引します。医薬品は、様々な病状の予防、治療、管理のために開発、製造、流通される薬や医薬品を包含し、効率的な生産、流通、監視のために効果的な医薬品サプライチェーンマネジメントに依存しています。これにより、必要不可欠なヘルスケア製品へのタイムリーなアクセスが確保されます。例えば、2023年6月の欧州製薬団体連合会のデータによると、欧州における医薬品の生産額は2021年の3,473億1,000万米ドル(3,239億5,000万ユーロ)から、2022年には3,642億6,000万米ドル(3,400億ユーロ)に増加し、4.88%の伸びを示しています。したがって、医薬品に対する需要の高まりが医薬品サプライチェーンマネジメント市場を活性化すると予想されます。

慢性疾患の増加は、医薬品サプライチェーンマネジメント市場の成長に貢献すると予想されます。慢性疾患は、3ヶ月以上続く長期的な病状を特徴とし、薬や治療の一貫した効率的な流れのために効果的な医薬品サプライチェーンマネジメントが必要となります。このアプローチは、遅れを減らし、コストを管理し、慢性疾患の管理に不可欠な薬剤をタイムリーに利用できるようにするのに役立ちます。2023年1月に米国国立衛生研究所(NIH)が報告したように、調査では米国の労働年齢層における慢性疾患の発生率が大幅に増加すると予測されており、2020年から2035年の間に少なくとも1つの慢性疾患を持つ50歳以上の患者が99.5%急増すると予測されています。このように、慢性疾患の増加は医薬品サプライチェーンマネジメント市場の重要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界医薬品サプライチェーンマネジメント PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の医薬品サプライチェーンマネジメント市場:成長率分析
  • 世界の医薬品サプライチェーンマネジメント市場の実績:規模と成長, 2019-2024
  • 世界の医薬品サプライチェーンマネジメント市場の予測:規模と成長, 2024-2029, 2034F
  • 世界医薬品サプライチェーンマネジメント総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の医薬品サプライチェーンマネジメント市場:コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ソリューション
  • サービス
  • 世界の医薬品サプライチェーンマネジメント市場:展開モード別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オンプレミス
  • クラウドベース
  • 世界の医薬品サプライチェーンマネジメント市場:最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ヘルスケアメーカー
  • ヘルスケア提供者
  • 販売代理店
  • ロジスティクス
  • 世界の医薬品サプライチェーンマネジメント市場、無線周波数識別(RFID)のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • RFIDペットタグ
  • RFID首輪
  • RFIDマイクロチップ
  • RFIDベースのペット識別システム
  • 世界の医薬品サプライチェーンマネジメント市場、全地球測位システム(GPS)のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • GPSペットトラッカー
  • GPS対応ペット用首輪
  • 活動と位置をモニターするGPSペットモニター
  • 世界の医薬品サプライチェーンマネジメント市場、センサーのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アクティビティセンサー(ペットフィットネストラッカー)
  • 健康モニタリングセンサー
  • モーションおよび行動センサー
  • 環境センサー
  • 世界の医薬品サプライチェーンマネジメント市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ペットカメラとモニター
  • スマートペットフィーダー
  • 自動トイレボックス
  • ウェアラブルペットデバイス

第7章 地域別・国別分析

  • 世界の医薬品サプライチェーンマネジメント市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の医薬品サプライチェーンマネジメント市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品サプライチェーンマネジメント市場:競合情勢
  • 医薬品サプライチェーンマネジメント市場:企業プロファイル
    • McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
    • AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
    • SAP SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • DSV Panalpina
  • UPS Healthcare
  • Parexel International Corporation
  • Spectrum Health Medical Group
  • Vizient Inc
  • Catalent Inc.
  • Infor Inc.
  • Epicor Software Corporation
  • Alvogen Inc.
  • Vetter Pharma International GmbH
  • Almac Group
  • Manhattan Associates Inc.
  • Global Healthcare Exchange LLC
  • CryoPDP
  • Tecsys Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 医薬品サプライチェーンマネジメント市場2029:新たな機会を提供する国
  • 医薬品サプライチェーンマネジメント市場2029:新たな機会を提供するセグメント
  • 医薬品サプライチェーンマネジメント市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r28738

Pharmaceutical supply chain management involves the strategic planning, implementation, and control of the flow of pharmaceutical products and related information from manufacturers to end-users. The primary goal is to ensure the secure distribution of pharmaceuticals while maintaining product quality, safety, and compliance with regulatory requirements.

The main components of pharmaceutical supply chain management include solutions and services. Solutions encompass products, services, or strategic approaches designed to address specific challenges faced by pharmaceutical organizations. These solutions may involve a combination of resources, expertise, or technology. The deployment modes for these solutions can be either on-premise or cloud-based. Pharmaceutical supply chain management is utilized by various end-users, including healthcare manufacturers, healthcare providers, distributors, and logistics entities.

The pharmaceutical supply chain management market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain management market statistics, including the pharmaceutical supply chain management industry global market size, regional shares, competitors with pharmaceutical supply chain management market share, detailed pharmaceutical supply chain management market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain management industry. This pharmaceutical supply chain management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical supply chain management market size has grown strongly in recent years. It will grow from $2.6 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to regulatory compliance, globalization, risk management, demand for personalized medicine, sustainability.

The pharmaceutical supply chain management market size is expected to see strong growth in the next few years. It will grow to $3.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to precision medicine, resilience planning, data security, e-commerce integration, real-time monitoring and visibility, circular economy initiatives. Major trends in the forecast period include digital transformation, technological advancements, collaboration and visibility, environmental sustainability, advanced analytics and ai integration, blockchain technology adoption.

The increasing demand for pharmaceutical products is poised to drive the growth of the pharmaceutical supply chain management market. Pharmaceutical products, which encompass medications and drugs developed, manufactured, and distributed for the prevention, treatment, or management of various medical conditions, rely on effective pharmaceutical supply chain management for efficient production, distribution, and monitoring. This ensures timely access to essential healthcare products. For example, data from the European Federation of Pharmaceutical Industries and Associations in June 2023 indicates that the production value of pharmaceuticals in Europe rose from 347.31 billion USD (323,950 million euros) in 2021 to 364.26 billion USD (340,000 million euros) in 2022, representing a 4.88% increase. Hence, the growing demand for pharmaceutical products is expected to fuel the pharmaceutical supply chain management market.

The increasing prevalence of chronic diseases is anticipated to contribute to the growth of the pharmaceutical supply chain management market. Chronic diseases, characterized by long-lasting medical conditions persisting for three months or more, necessitate effective pharmaceutical supply chain management for a consistent and efficient flow of medications and treatments. This approach helps reduce delays, control costs, and ensure the timely availability of medications crucial for managing chronic conditions. As reported by the National Institutes of Health (NIH) in January 2023, research anticipates a substantial increase in the incidence of chronic illnesses within the U.S. working-age demographic, projecting a 99.5% surge in individuals aged 50 and above with at least one chronic disease between 2020 and 2035. Thus, the growing prevalence of chronic diseases is a key driver for the pharmaceutical supply chain management market.

Key players in the pharmaceutical supply chain management market are actively developing innovative products such as multi-enterprise supply chain work management solutions to streamline processes and enhance collaboration across the pharmaceutical supply chain. Multi-enterprise supply chain work management solutions are specialized software or platforms designed to optimize various supply chain processes across multiple organizations within the pharmaceutical sector. For example, in April 2022, TraceLink Inc., a US-based company providing supply chain work management solutions, introduced the TraceLink supply chain work management solution-a multi-enterprise solution for the healthcare and life sciences industries. This solution aims to facilitate collaborative networks among companies and their trading partners, enhancing the performance of integrated supply planning and execution processes. It effectively manages supply chain issues and planning exceptions, such as material shortages, short shipments, and forecast changes. The solution offers actionable visibility and customizable business process templates for supply chain management, leading to improved fill rates, cost reduction, and enhanced supply plan performance.

In March 2022, Symplr Software LLC, a US-based company specializing in the development of governance, risk, and compliance management software for healthcare facilities, successfully acquired GreenLight Medical for an undisclosed amount. This strategic acquisition is intended to bolster Symplr's healthcare operations portfolio by integrating the specialized medical supply chain management software developed by GreenLight. By incorporating GreenLight's expertise and solutions, Symplr aims to offer its clients enhanced services in the supply chain management sector. This initiative seeks to address the challenges faced by healthcare organizations in supply procurement. GreenLight Medical, the acquired entity, is a US-based provider of healthcare supply chain management solutions.

Major companies operating in the pharmaceutical supply chain management market report are McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health Inc., Oracle Corporation, SAP SE, DSV Panalpina, UPS Healthcare, Parexel International Corporation, Spectrum Health Medical Group, Vizient Inc., Catalent Inc., Infor Inc., Epicor Software Corporation, Alvogen Inc., Vetter Pharma International GmbH, Almac Group, Manhattan Associates Inc., Global Healthcare Exchange LLC, CryoPDP, Tecsys Inc., Arvato Supply Chain Solutions, Terso Solution, Logitag Systems, Jump Technologies, Chain.io Inc.

Asia-Pacific was the largest region in the pharmaceutical supply chain management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical supply chain management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pharmaceutical supply chain management market includes revenues earned by entities by providing services such as logistics and distribution, cold chain management, inventory management, and quality control and assurance services that are used to optimize the pharmaceutical supply chain for the delivery of vital medications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pharmaceutical supply chain management market consists of sales of cold chain equipment, warehouse automation systems, and automated guided vehicles. to provide pharmaceutical companies with opportunities to optimize the supply chain operations of pharmaceutical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Supply Chain Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical supply chain management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical supply chain management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical supply chain management market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Solution; Service
  • 2) By Deployment Mode: On-Premise; Cloud Based
  • 3) By End-Use: Healthcare Manufacturers; Healthcare Providers; Distributors; Logistics
  • Subsegments:
  • 1) By Solution: Supply Chain Management Software; Inventory Management Systems; Order Management Systems; Transportation Management Solutions; Warehouse Management Solutions; Track And Trace Solutions; Demand Forecasting Solutions; Cold Chain Monitoring Solutions
  • 2) By Service: Consulting Services; Integration And Implementation Services; Managed Services; Support And Maintenance Services; Logistics And Distribution Services; Training And Education Services
  • Companies Mentioned: McKesson Corporation; AmerisourceBergen Corporation; Cardinal Health Inc.; Oracle Corporation; SAP SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Supply Chain Management Market Characteristics

3. Pharmaceutical Supply Chain Management Market Trends And Strategies

4. Pharmaceutical Supply Chain Management Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharmaceutical Supply Chain Management Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Supply Chain Management PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Supply Chain Management Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Supply Chain Management Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Supply Chain Management Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Supply Chain Management Total Addressable Market (TAM)

6. Pharmaceutical Supply Chain Management Market Segmentation

  • 6.1. Global Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solution
  • Service
  • 6.2. Global Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premise
  • Cloud Based
  • 6.3. Global Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Manufacturers
  • Healthcare Providers
  • Distributors
  • Logistics
  • 6.4. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Radio Frequency Identification (RFID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RFID Pet Tags
  • RFID Collars
  • RFID Microchips
  • RFID-Based Pet Identification Systems
  • 6.5. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Global Positioning System (GPS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • GPS Pet Trackers
  • GPS-enabled Pet Collars
  • GPS Pet Monitors For Activity And Location
  • 6.6. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Activity Sensors (Pet Fitness Trackers)
  • Health Monitoring Sensors
  • Motion And Behavior Sensors
  • Environmental Sensors
  • 6.7. Global Pharmaceutical Supply Chain Management Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pet Cameras and Monitors
  • Smart Pet Feeders
  • Automatic Litter Boxes
  • Wearable Pet Devices

7. Pharmaceutical Supply Chain Management Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Supply Chain Management Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Supply Chain Management Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Supply Chain Management Market

  • 8.1. Asia-Pacific Pharmaceutical Supply Chain Management Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Supply Chain Management Market

  • 9.1. China Pharmaceutical Supply Chain Management Market Overview
  • 9.2. China Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Supply Chain Management Market

  • 10.1. India Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Supply Chain Management Market

  • 11.1. Japan Pharmaceutical Supply Chain Management Market Overview
  • 11.2. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Supply Chain Management Market

  • 12.1. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Supply Chain Management Market

  • 13.1. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Supply Chain Management Market

  • 14.1. South Korea Pharmaceutical Supply Chain Management Market Overview
  • 14.2. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Supply Chain Management Market

  • 15.1. Western Europe Pharmaceutical Supply Chain Management Market Overview
  • 15.2. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Supply Chain Management Market

  • 16.1. UK Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Supply Chain Management Market

  • 17.1. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Supply Chain Management Market

  • 18.1. France Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Supply Chain Management Market

  • 19.1. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Supply Chain Management Market

  • 20.1. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Supply Chain Management Market

  • 21.1. Eastern Europe Pharmaceutical Supply Chain Management Market Overview
  • 21.2. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Supply Chain Management Market

  • 22.1. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Supply Chain Management Market

  • 23.1. North America Pharmaceutical Supply Chain Management Market Overview
  • 23.2. North America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Supply Chain Management Market

  • 24.1. USA Pharmaceutical Supply Chain Management Market Overview
  • 24.2. USA Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Supply Chain Management Market

  • 25.1. Canada Pharmaceutical Supply Chain Management Market Overview
  • 25.2. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Supply Chain Management Market

  • 26.1. South America Pharmaceutical Supply Chain Management Market Overview
  • 26.2. South America Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Supply Chain Management Market

  • 27.1. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Supply Chain Management Market

  • 28.1. Middle East Pharmaceutical Supply Chain Management Market Overview
  • 28.2. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Supply Chain Management Market

  • 29.1. Africa Pharmaceutical Supply Chain Management Market Overview
  • 29.2. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Supply Chain Management Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Supply Chain Management Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Supply Chain Management Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Supply Chain Management Market Competitive Landscape
  • 30.2. Pharmaceutical Supply Chain Management Market Company Profiles
    • 30.2.1. McKesson Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SAP SE Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Supply Chain Management Market Other Major And Innovative Companies

  • 31.1. DSV Panalpina
  • 31.2. UPS Healthcare
  • 31.3. Parexel International Corporation
  • 31.4. Spectrum Health Medical Group
  • 31.5. Vizient Inc
  • 31.6. Catalent Inc.
  • 31.7. Infor Inc.
  • 31.8. Epicor Software Corporation
  • 31.9. Alvogen Inc.
  • 31.10. Vetter Pharma International GmbH
  • 31.11. Almac Group
  • 31.12. Manhattan Associates Inc.
  • 31.13. Global Healthcare Exchange LLC
  • 31.14. CryoPDP
  • 31.15. Tecsys Inc.

32. Global Pharmaceutical Supply Chain Management Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Supply Chain Management Market

34. Recent Developments In The Pharmaceutical Supply Chain Management Market

35. Pharmaceutical Supply Chain Management Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Supply Chain Management Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Supply Chain Management Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Supply Chain Management Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer